Worldwide Clinical Trials
Andrea Smith, MBA, currently serves as the Associate Director of Global FP&A at Worldwide Clinical Trials, focusing on financial planning, reporting, modeling, and analysis to support data-driven decision making. Prior to this role, Andrea spent over 15 years at Spok as a Finance Manager, providing comprehensive financial support across management levels in a critical communications firm. Experience also includes serving as a Senior Financial Analyst at Level 3 Communications, where Andrea held key accounting and finance positions, and as an Accounting Specialist at General Bandwidth, contributing to the development of accounting policies. Early career experience includes a role as Billing & Job Cost Manager at Harte-Hanks, Inc. Andrea holds an MBA and a BBA in Accounting from Texas State University.
This person is not in any teams
This person is not in any offices
Worldwide Clinical Trials
11 followers
About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.